VectorY
VectorY Therapeutics is a clinical-stage biotechnology company developing novel genetic medicines for neurodegenerative diseases using its proprietary Vectorized Antibody Platform, which combines AAV-based gene delivery with antibody engineering to express therapeutic antibodies directly in the central nervous system. Its pipeline targets amyotrophic lateral sclerosis (ALS) with VTx-002 and VTx-001 and Huntington's disease with VTx-003. The company was surfaced as a portfolio company of Insight Partners and added to the API Evangelist network. As a therapeutics research organization, VectorY publishes a corporate website, pipeline, scientific publications, news, and careers, but operates no public developer API, documentation portal, or programmatic interface surface.
VectorY is profiled on the APIs.io network. Tagged areas include Company, Biotech, Therapeutics, Gene Therapy, and Neurodegenerative Disease.
VectorY’s developer surface includes engineering blog and 4 more developer resources.
Kin Score
Resources
Operate 1
Status, limits, changes, and where to get help
Company 4
The organization behind the API